Keryx Share Price - The Market The PE ratio of Keryx Biopharmaceuticals is -382 which means that its earnings are negative and its PE ratio cannot be compared to companies with positive earnings. If Keryx Biopharmaceuticals manages to completely convert its outstanding convertible notes the pro forma equity value of the combined company would be.
Here S Why Keryx Biopharmaceuticals And Akebia Therapeutics Are Plunging Today The Motley Fool
It is down 903 and has underperformed the SP 500 in part reflecting.
Keryx share price. Keryx biopharmaceuticals NASDAQKERX Share Price and News. Akebia and Keryx expect deal to close by year-end Jun. Find the latest 513152 KERX stock quote history news and other vital information to help you with your stock trading and investing.
Over the past six months the relative strength of its shares against the market has been -397. Keryxs share price has decreased 26 year to date while the Zacks classified Medical - Biomedical and Genetics industry gained 96. Free forex prices toplists indices and lots more.
Akebias current president and CEO John Butler will lead the new company. The share price came within pennies of a recently set 52 week high to hit 1484 only to fall drastically that same day. Very liquid calls and puts.
ET by Ciara Linnane Akebia and Keryx say deal will create company with pro forma equity value of about 13 bln. And Encourages Investors Who Formerly Held Shares of Keryx Biopharmaceuticals KERX to Contact the Firm Newsfile Corp - Fri Jun 18 1159AM CDT. Kerx 3800 s-0120 -306.
KERX has an average dollar-volume as measured by average daily share volume multiplied by share price of 135 million. The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics Inc. Price to Earnings Ratio vs.
Latest stock price today and the USs most active stock market forums. The company markets its lead product Auryxia ferric citrate an orally available absorbable iron-based medicine for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. The average price target represents a -10000 upside from the last price of 336.
Earnings for Keryx Biopharmaceuticals are expected to grow in the coming year from 058 to 026 per share. Delisted KERX stock price charts trades the USs most popular discussion forums. Price trends tend to persist so its worth looking at them when it comes to a share like Keryx Biopharmaceuticals Inc.
If Keryx Biopharmaceuticals manages to completely convert its outstanding convertible notes the pro forma equity value of the combined company would be 13 billion based on the closing share price of the companies on June 28. 513152 KERX Stock Price News Quote History - Yahoo Finance. Keryx Biopharmaceuticals KERX enters into a definitive merger agreement with Akebia Therapeutics Inc.
NASDAQKERX is a biopharmaceutical company focused on the. KERX is up 3 today. KERX has traded 699249 shares today.
The share price of KERYX BIOPHARMACEUTICALS INC has not done very well. View daily weekly or monthly format back to when 513152 stock was issued. Goldman Sachs Morgan Stanley and Cowen and Company served as the underwriters for the IPO and Baird was co-manager.
The biggest decline for Keryx came on December 5th. 422000 net Avg Volume. Pantginis raised his price target on Keryx shares to.
Under which the companies will combine in an all-stock merger. 28 2018 at 706 am. This price target is based on 0 analysts offering 12 month price targets for Keryx Biopharmaceuticals in the last 3 months.
BGNE raised 126 million in an initial public offering on Wednesday February 3rd 2016. Discover historical prices for KERX stock on Yahoo Finance. At the current price of 336 shares.
Phosphate binder sales exceeded 1 billion worldwide in 2009 with more than 700 million coming from US. Keryx Biopharmaceuticals merged with Akebia Therapeutics. 294 -134 Investigation Alert.
Keryx shareholders will receive 037433 shares of the newly formed company for each share currently owned. The average price target is 000 with a high forecast of 000 and a low forecast of 1000000000. 336 -204 AKBA.
The company issued 5500000 shares at a price of 2200-2400 per share.
Pin On Hill Country Times
Keryx Biopharma Kerx Stock Chart
Why Is Keryx Kerx Down 2 7 Since Its Last Earnings Report
Document
What S Behind Keryx Biopharmaceuticals 28 6 Jump In September The Motley Fool
Here S Why Keryx Biopharmaceuticals Dropped 19 6 In August The Motley Fool
Keryx Biopharmaceuticals Stock Forecast Down To 2 597 Usd Kerx Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis
What S Behind Keryx Biopharmaceuticals 28 6 Jump In September The Motley Fool
Keryx Biopharmaceuticals Stock Forecast Down To 2 597 Usd Kerx Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis
Keryx Tradingview
Keryx Tradingview
Keryx Biopharmaceuticals Stock Forecast Down To 2 597 Usd Kerx Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis
Keryx Kerx Looks Good Stock Adds 7 2 In Session
Keryx Kerx Inks Merger Deal With Akebia Shares Fall Nasdaq
